Folic acid
5 mg № 50
Group of action
Active ingredient
Dosage form
Tablets
ATC code
B03BB01
RX/OTC
RX
Marketing authorisation no.
UA/4380/01/02
General properties
Pharmacotherapeutic group
Anti-anaemic preparations. Folic acid and its derivatives.
Indications
- Treatment and prevention of anaemia due to folic acid deficiency: macrocytic anaemia, anaemia and leukopenia which are drug-induced or caused by ionizing radiation; megaloblastic anaemia, post-resection anaemia and sideroblastic anaemia in elderly patients; anaemia due to diseases of the small intestine, sprue and malabsorption syndrome;
- Prevention of birth defects in the foetus: neural tube defects, hydrocephalus, cleft palate, cleft lip and cephalocele;
- Long-term treatment with folic acid antagonists (methotrexate, trimethoprim-sulfamethoxazole combination), anticonvulsants (phenytoin, primidone, phenobarbital);
- folic acid deficiency associated with an unbalanced diet or malnutrition;
- Treatment of male infertility due to a decrease in spermatogenesis (oligospermia);
- Polyneuritis and polyneuropathy, including alcoholic etiology.
Contraindications
Hypersensitivity to folic acid or other components of the drug, malignant neoplasms, malignant anaemia, untreated cobalamin deficiency.
Pharmaceutical characteristics
Basic physical and chemical properties
5 mg tablets - flat-faced bisect, yellow to dark yellow tablets.
Shelf life
3 years.
Storage conditions
Store in original packaging at temperatures not exceeding 25 °C.
Keep out of the reach of children.
RX
Manufacturer
JSC Technolog.
Location
8, Manuilskogo str., Uman, Cherkasy region, Ukraine, 20300.
